A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 71, Issue 9, Pages 2634-2641
Publisher
Oxford University Press (OUP)
Online
2016-06-18
DOI
10.1093/jac/dkw199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology
- (2014) Daniela Tacke et al. ANNALS OF HEMATOLOGY
- Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study
- (2014) N. Lerolle et al. CLINICAL MICROBIOLOGY AND INFECTION
- Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: A 6-yr analysis from the cologne cohort for neutropenic patients
- (2014) Maria J. G. T. Vehreschild et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study
- (2014) David Nachbaur et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Our 2014 approach to breakthrough invasive fungal infections
- (2014) Georg Maschmeyer et al. MYCOSES
- Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study
- (2014) Hsiang-Chi Kung et al. Cancer Medicine
- Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
- (2013) Sabine Mousset et al. ANNALS OF HEMATOLOGY
- Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry
- (2012) L. Pagano et al. CLINICAL INFECTIOUS DISEASES
- Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study
- (2012) J. Auberger et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
- (2011) Alison G. Freifeld et al. CLINICAL INFECTIOUS DISEASES
- Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period
- (2011) M. R. Ananda-Rajah et al. HAEMATOLOGICA
- Efficacy, Safety, and Breakthrough Infections Associated with Standard Long-Term Posaconazole Antifungal Prophylaxis in Allogeneic Stem Cell Transplantation Recipients
- (2010) Drew J. Winston et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update
- (2010) J Maertens et al. BONE MARROW TRANSPLANTATION
- Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort
- (2010) J. J. Vehreschild et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species
- (2009) P. A. Mann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
- (2008) Brahm H. Segal et al. CLINICAL INFECTIOUS DISEASES
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
- (2008) Ben De Pauw et al. CLINICAL INFECTIOUS DISEASES
- Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies
- (2008) Jutta Auberger et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started